Image

Global Pompe Disease Treatment Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Pompe Disease Treatment Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Pompe Disease Treatment Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 1.40 USD Billion
Diagram Market Size (Forecast Year) USD 1.92 USD Billion
Diagram CAGR %

Major Markets Players

  • Amicus Therapeutics
  • Audentes Therapeutics
  • Novartis
  • Fresenius Kabi
  • Akorn orporated

Global Pompe Disease Treatment Market, By Type (Classic Infantile Form, Non-Classic Infantile Form, Late-Onset Form, Others), Diagnosis (Blood Test, Genetic Test, Prenatal Test, Others), Treatment (Enzyme Replacement Therapy, Supportive Therapies, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Pompe Disease Treatment Market

Pompe Disease Treatment Market Analysis and Size

The global pompe disease treatment market is projected to witness significant growth during the forecast period. In U.S., projected occurrence are approximately 1 in 40,000 births. Males and females are equally affected by the diseases. Medical advancements that involves ongoing drug discovery, and government and non-government organizational initiatives are what that boosts the market growth.  

Data Bridge Market Research analyses a growth rate in the global pompe disease treatment market in the forecast period 2022-2029. The expected CAGR of global pompe disease treatment market tend to be around 4% in the mentioned forecast period. The market was valued at USD 1.4 billion in 2021, and it would grow upto USD 1.92 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Pompe disease is an autosomal recessive inherited disorder caused by pathogenic variations in the acid alpha-glucosidase (GAA) gene. It is characterized by the abnormal build up of sugar (glycogen) inside the cells, this sugar builds up the working of different organs and tissues, specifically heart, skeletal muscles and respiratory tract. Patients suffering from the classic infantile form type of pompe disease are most affect patients. In infants, symptoms are usually seen in three months with rapidly muscle weakness, respiratory insufficiency, hypertrophic cardiomyopathy. 

Pompe Disease Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Classic Infantile Form, Non-Classic Infantile Form, Late-Onset Form, Others), Diagnosis (Blood Test, Genetic Test, Prenatal Test, Others), Treatment (Enzyme Replacement Therapy, Supportive Therapies, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Amicus Therapeutics, Inc (U.S.), Audentes Therapeutics (U.S.), Novartis AG (Switzerland), Fresenius Kabi AG (Germany), Akorn Incorporated (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Mylan N.V (U.S.), Johnsons & Johnsons Services Inc (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Danaher. (U.S.), B.D. (U.S.), Chembio Diagnostics (U.S.), EKF Diagnostics (U.K.), Trinity Biotech plc (Ireland), Instrumentation Laboratory (U.S.), Nova Biomedical (U.S.), PTS Diagnostics (U.S.), Sekisui Diagnostics (U.S.), Thermo Fisher Scientific (U.S.), bioMérieux S.A. (France)

Market Opportunities

  • Increased Research and Clinical Activities
  • Rising Demand of Advanced Treatments

Global Pompe Disease Treatment Market Dynamics

Drivers

  • Increased Incidence of Pompe Disease

Pompe disease affects 1 in 40,000 individuals in the U.S. It has been observed that the total carrier frequency (C.F.) and predicted genetic prevalence (pGP) were about 1.3 % and 1:23,232, respectively. Its frequency is growing and its treatment is of great importance to the healthcare sector.

  • Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is projected to increase the global market as most products are available in capsule and tablet form and it is a very convenient route of administration.

Opportunities

  • Increased Research and Clinical Activities

Launching novel drugs globally will boost the demand for treatment of pompe disease and boost the market growth. In addition to this, increasing R&D expenditure will more involvement on novel therapeutics of pompe diseases as this is a very vital and fatal disease. For Instance, Genethon developed a gene therapy clinical trial for late-onset Pompe disease in February 2021 using technologies developed at Genethon. This creates more opportunity in the market.

  • Rising Demand of Advanced Treatments

The growing incidence of Pompe disease provides opportunities for treatment providers who have developed several new products and services that are focused on improving patient outcomes through numerous medications, medical devices, surgical procedures, rehabilitation therapies, pharmaceuticals, and other interventions. Thus, these treatments create more opportunities for the market growth.

Restraints/Challenges

  • Lack of Skilled Professionals

Lack of trained professionals who are unaware of the treatment methods for this disease could curb the growth of the global pompe disease treatment market over a forecast period.

  • High Cost

The huge expenditure of the treatment methods hamper the market growth. The treatment for this diseased condition is expensive, and only about one-third of patients who receive it survive beyond five years. There is a high degree of unmet medical need for pompe disease treatment.

This global pompe disease treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pompe disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Pompe Disease Treatment Market

COVID-19 has left a global public health crisis that has impacted practically every business. The transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.

The global pompe disease treatment market witnessed a huge negative transition during the COVID-19 pandemic as there was a decline in patient hospitalizations. Only emergency and primary care services are available during COVID-19. Patients suffering from pompe disease are at very high risk. Thus, COVID-19 significantly impacted the pompe diseases market. 

Global Pompe Disease Treatment Market Scope

The global pompe disease treatment market is segmented on the basis of type, diagnosis, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Classic Infantile Form
  • Non-Classic Infantile Form
  • Late-Onset Form
  • Others

Diagnosis

Treatment

  • Enzyme Replacement Therapy
  • Supportive Therapies
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Others

End-Users

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Pompe Disease Treatment Market Regional Analysis/Insights

The global pompe disease treatment market is analysed and market size insights and trends are provided by type, diagnosis, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global pompe disease treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the pompe disease treatment market due to the presence of major key players, high disposable income and well-developed healthcare sector in this region.

Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Pompe Disease Treatment Market Share Analysis

The global pompe disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global pompe disease treatment market .

Key players operating in the global pompe disease treatment market include:

  • Amicus Therapeutics, Inc (U.S.)
  • Audentes Therapeutics (U.S.)
  • Novartis AG (Switzerland)
  • Fresenius Kabi AG (Germany)
  • Akorn Incorporated (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Mylan N.V (U.S.)
  • Johnsons & Johnsons Services Inc (U.S.)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher. (U.S.)
  • B.D. (U.S.)
  • Chembio Diagnostics (U.S.)
  • Sekisui Diagnostics (US)
  • Thermo Fisher Scientific (U.S.)
  • bioMérieux S.A. (France)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Pompe Disease Treatment Market is projected to grow at a CAGR of 4.0% during the forecast period by 2029.
The future market value of the Pompe Disease Treatment Market is expected to reach USD 1.92 billion by 2029.
The major players in the Pompe Disease Treatment Market are Amicus Therapeutics, Inc (U.S.), Audentes Therapeutics (U.S.), Novartis AG (Switzerland), Fresenius Kabi AG (Germany), Akorn Incorporated (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Mylan N.V (U.S.), etc.
The countries covered in the Pompe Disease Treatment Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials